P1187: END OF TREATMENT 18F FDG-PET/CT RESPONSE IS PROGNOSTIC FOR OVERALL AND PROGRESSION-FREE SURVIVAL IN PERIPHERAL T-CELL LYMPHOMA: RESULTS OF THE UK NCRI PHASE 2 RANDOMISED CHEMO-T TRIAL PET/CT SUBSTUDY

Detalles Bibliográficos
Autores principales: Gleeson, M., Arias, C., Cunningham, D., Peckitt, C., Du, Y., Hujairi, N., To, Y. M., Chen, H.-C., Patel, S., Chau, I., Johnson, P., Ardeshna, K. M., Wotherspoon, A., Attygalle, A., Hawkes, E. A., Macheta, M. P., Collins, G. P., Radford, J., Forbes, A., Hart, A., Montoto, S., McKay, P., Benstead, K., Morley, N., Kalakonda, N., Hasan, Y., Turner, D., Chua, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429374/
http://dx.doi.org/10.1097/01.HS9.0000847612.86972.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429374/
http://dx.doi.org/10.1097/01.HS9.0000847612.86972.11

Ejemplares similares